PLXNA1 (Plexin A1) encodes a transmembrane receptor for semaphorins, playing critical roles in axonal guidance, neural circuit formation, and synaptic plasticity throughout development and in the adult nervous system. As a member of the plexin family of guidance receptors, PLXNA1 regulates cytoskeletal dynamics through interactions with small GTPases and downstream signaling cascades. Dysregulation of PLXNA1 has been implicated in neurodegenerative diseases including Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS), as well as in cancer progression and neurodevelopmental disorders.
¶ Gene Structure and Expression
The PLXNA1 gene is located on chromosome 3q21.3 and encodes a 2,018 amino acid transmembrane receptor protein with a molecular weight of approximately 210 kDa. The gene spans approximately 85 kb and consists of 31 exons.
PLXNA1 exhibits high expression in:
- Cerebral cortex — Pyramidal neurons throughout all layers
- Hippocampus — CA1-CA3 pyramidal cells and dentate gyrus granule cells
- Cerebellum — Purkinje cells
- Spinal cord — Motor neurons (alpha and gamma motor neurons)
- Dorsal root ganglia — Sensory neurons
- Developing brain — Particularly during embryogenesis and early postnatal periods
Expression is maintained in adulthood but at lower levels, with region-specific patterns reflecting ongoing plasticity in specific brain circuits.
¶ Protein Structure and Function
¶ Domain Architecture
Plexin A1 contains several conserved domains:
-
Extracellular Domain
- Sema domain (~500 aa) — High-affinity semaphorin binding
- PSI domains (3x) — Plexin-Semaphorin-Integrin motifs
- IPT/TIG domains (4x) — Immunoglobulin-like folds
-
Transmembrane Domain
- Single-pass membrane anchor
- Dimerization interface
-
Cytoplasmic Domain
- Plexin homology (PH) domain — Contains GTPase-activating protein (GAP) activity
- C-terminal region — Required for downstream signaling
¶ Semaphorin Ligands
PLXNA1 serves as a receptor for multiple Class 3 semaphorins:
- SEMA3A — Primary ligand, potent axonal repulsion
- SEMA3B — Tumor suppressor functions
- SEMA3C — Both repulsive and attractive effects
- SEMA3F — Anti-angiogenic properties
- SEMA3D — Mixed effects on axon guidance
Upon semaphorin binding, PLXNA1 activates multiple downstream pathways:
GTPase Regulation:
- GAP activity toward R-Ras, M-Ras, and Rap1
- Inactivation of integrins and promotion of growth cone collapse
- Regulation of actin cytoskeleton dynamics
Kinase Cascades:
- PI3K/Akt pathway — Cell survival signaling
- MAPK/ERK pathway — Growth and differentiation
- FAK activation — Focal adhesion turnover
Cellular Responses:
- Growth cone collapse and axonal repulsion
- Dendritic branching modulation
- Synaptic structure remodeling
- Angiogenesis regulation
PLXNA1 is implicated in AD through multiple mechanisms:
Synaptic Dysfunction:
- Regulates dendritic spine morphology and synaptic plasticity
- SEMA3A/PLXNA1 signaling modulates AMPA receptor trafficking
- Dysregulated signaling contributes to synaptic loss in AD
Neuronal Circuit Alterations:
- Critical for hippocampal circuit formation and function
- May influence tau pathology spread through connected networks
- Implicated in memory consolidation deficits
Amyloid-Beta Interaction:
- Aβ oligomers disrupt normal PLXNA1 signaling
- Altered semaphorin/plexin gradients in AD brain
- Potential for therapeutic targeting
PLXNA1 plays important roles in ALS pathophysiology:
Motor Neuron Vulnerability:
- Essential for axonal maintenance in upper and lower motor neurons
- SEMA3A toxicity mediated through PLXNA1
- Dysregulated axonal guidance signaling
Axonal Transport:
- Regulates microtubule dynamics
- Impaired transport in ALS models
- Contributes to distal axonopathy
Therapeutic Target:
- SEMA3A antagonists protective in ALS models
- PLXNA1 modulators under investigation
- PLXNA1 acts as a tumor suppressor in certain contexts
- Loss of PLXNA1 promotes tumor progression
- Anti-angiogenic therapy target
- Mutations associated with brain malformations
- Implicated in schizophrenia through GWAS
- Potential role in autism spectrum disorders
PLXNA1-mediated semaphorin signaling controls growth cone behavior through:
- Rapid actin depolymerization at leading edge
- Microtubule destabilization
- Focal adhesion disassembly
- RhoA/ROCK-dependent contractility
At mature synapses, PLXNA1 regulates:
- Dendritic spine morphogenesis
- AMPA receptor trafficking
- Long-term potentiation (LTP) and depression (LTD)
- Homeostatic synaptic scaling
Microglial and astrocyte responses are modulated by PLXNA1:
- Regulates cytokine production
- Affects glial scar formation
- Modulates neuroinflammation in disease states
PLXNA1 interacts with:
- NRP1/NRP2 — Neuropilin co-receptors
- PLXNA2/PLXNA3/PLXNA4 — Plexin family members
- RND1/RND2/RND3 — Rho GTPase family
- FAK — Focal adhesion kinase
- SRC — Proto-oncogene tyrosine kinase
- PI3K — Phosphoinositide 3-kinase
- IQGAP1 — Scaffold protein
Key downstream cascades:
- RhoA/ROCK — Cytoskeletal remodeling
- R-Ras GAP — Integrin signaling
- PI3K/Akt — Survival pathway
- MAPK/ERK — Proliferation/differentiation
- SEMA3A inhibitors — Reduce semaphorin-mediated toxicity
- Plexin agonists — Promote neuroprotective signaling
- GAP domain modulators — Target downstream effectors
- AAV-mediated PLXNA1 modulation
- CRISPR approaches for mutation correction
- Cell-type specific targeting
- PLXNA1 expression as a biomarker for neural circuit integrity
- Genetic variants for risk stratification
- Structural biology — Plexin-Semaphorin complex structures
- Single-cell analysis — Cell-type specific expression patterns
- ALS therapeutics — SEMA3A/PLXNA1 pathway inhibitors
- Circuit mapping — Functional connectivity studies
- Mechanisms in sporadic AD
- Cell-type specific vulnerabilities
- Long-term effects of therapeutic modulation